WO2001007915A2 - Layered device with capture regions for cellular analysis - Google Patents
Layered device with capture regions for cellular analysis Download PDFInfo
- Publication number
- WO2001007915A2 WO2001007915A2 PCT/US2000/020354 US0020354W WO0107915A2 WO 2001007915 A2 WO2001007915 A2 WO 2001007915A2 US 0020354 W US0020354 W US 0020354W WO 0107915 A2 WO0107915 A2 WO 0107915A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- substrate
- specimen
- layers
- cellular
- components
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6841—In situ hybridisation
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B30/00—Methods of screening libraries
- C40B30/04—Methods of screening libraries by measuring the ability to specifically bind a target molecule, e.g. antibody-antigen binding, receptor-ligand binding
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
- G01N33/54386—Analytical elements
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57434—Specifically defined cancers of prostate
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6845—Methods of identifying protein-protein interactions in protein mixtures
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/4712—Muscle proteins, e.g. myosin, actin, protein
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/4742—Keratin; Cytokeratin
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/70503—Immunoglobulin superfamily, e.g. VCAMs, PECAM, LFA-3
- G01N2333/7051—T-cell receptor (TcR)-CD3 complex
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
- G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
- G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
- G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
- G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
- G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
- G01N2333/96433—Serine endopeptidases (3.4.21)
- G01N2333/96441—Serine endopeptidases (3.4.21) with definite EC number
- G01N2333/96455—Kallikrein (3.4.21.34; 3.4.21.35)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
- G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
- G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
- G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
- G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
- G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
- G01N2333/96486—Metalloendopeptidases (3.4.24)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Computational Biology (AREA)
- Zoology (AREA)
- Hospice & Palliative Care (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Investigating Or Analysing Materials By Optical Means (AREA)
Abstract
Description
Claims
Priority Applications (13)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA2375034A CA2375034C (en) | 1999-07-26 | 2000-07-26 | Method and device for analysis of biological specimens |
EP00953685A EP1218743B1 (en) | 1999-07-26 | 2000-07-26 | Layered device with capture regions for cellular analysis |
JP2001512292A JP4137444B2 (en) | 1999-07-26 | 2000-07-26 | Layered device with capture area for cell analysis |
AU66091/00A AU771499B2 (en) | 1999-07-26 | 2000-07-26 | Layered device with capture regions for cellular analysis |
DE60028393T DE60028393T2 (en) | 1999-07-26 | 2000-07-26 | LAYER DEVICE WITH INTENDED RANGE FOR CELLULAR ANALYSIS |
US10/048,194 US7214477B1 (en) | 1999-07-26 | 2000-07-26 | Layered device with capture regions for cellular analysis |
US09/718,990 US6602661B1 (en) | 1999-07-26 | 2000-11-20 | Methods and arrays for detecting biomolecules |
US10/432,423 US6969615B2 (en) | 1999-07-26 | 2001-11-20 | Methods, devices, arrays and kits for detecting and analyzing biomolecules |
US10/627,352 US20040081987A1 (en) | 1999-07-26 | 2003-07-25 | Methods and arrays for detecting biomolecules |
US11/189,038 US20060275851A1 (en) | 2000-07-26 | 2005-07-26 | Layered peptide/antigen arrays - for high-throughput antibody screening of clinical samples |
US11/277,227 US7838222B2 (en) | 1999-07-26 | 2006-03-22 | Methods, devices and kits for multiplex blotting of biological samples from multi-well plates |
US12/289,736 US20090215073A1 (en) | 2000-07-26 | 2008-11-03 | Layered peptide/antigen arrays - for high-throughput antibody screening of clinical samples |
US12/626,405 US8779312B2 (en) | 1999-07-26 | 2009-11-25 | Method and device for analyzing biomolecules with track-etched polymeric layers |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14561399P | 1999-07-26 | 1999-07-26 | |
US60/145,613 | 1999-07-26 |
Related Parent Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/048,194 Continuation-In-Part US7214477B1 (en) | 1999-07-26 | 2000-07-26 | Layered device with capture regions for cellular analysis |
PCT/US2000/020354 Continuation-In-Part WO2001007915A2 (en) | 1999-07-26 | 2000-07-26 | Layered device with capture regions for cellular analysis |
Related Child Applications (5)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/048,194 A-371-Of-International US7214477B1 (en) | 1999-07-26 | 2000-07-26 | Layered device with capture regions for cellular analysis |
PCT/US2000/020354 Continuation-In-Part WO2001007915A2 (en) | 1999-07-26 | 2000-07-26 | Layered device with capture regions for cellular analysis |
US09/718,990 Continuation-In-Part US6602661B1 (en) | 1999-07-26 | 2000-11-20 | Methods and arrays for detecting biomolecules |
US11/189,038 Continuation-In-Part US20060275851A1 (en) | 2000-07-26 | 2005-07-26 | Layered peptide/antigen arrays - for high-throughput antibody screening of clinical samples |
US11/277,227 Continuation-In-Part US7838222B2 (en) | 1999-07-26 | 2006-03-22 | Methods, devices and kits for multiplex blotting of biological samples from multi-well plates |
Publications (3)
Publication Number | Publication Date |
---|---|
WO2001007915A2 true WO2001007915A2 (en) | 2001-02-01 |
WO2001007915A3 WO2001007915A3 (en) | 2001-04-05 |
WO2001007915A8 WO2001007915A8 (en) | 2001-11-22 |
Family
ID=22513857
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2000/020354 WO2001007915A2 (en) | 1999-07-26 | 2000-07-26 | Layered device with capture regions for cellular analysis |
Country Status (9)
Country | Link |
---|---|
US (2) | US6602661B1 (en) |
EP (1) | EP1218743B1 (en) |
JP (1) | JP4137444B2 (en) |
AT (1) | ATE328277T1 (en) |
AU (1) | AU771499B2 (en) |
CA (1) | CA2375034C (en) |
DE (1) | DE60028393T2 (en) |
ES (1) | ES2269171T3 (en) |
WO (1) | WO2001007915A2 (en) |
Cited By (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002010751A2 (en) * | 2000-07-26 | 2002-02-07 | The Government Of The United States Of America, As Represented By The Secretary, Department Of Health & Human Services | Transfer microdissection |
WO2003014738A2 (en) * | 2001-08-02 | 2003-02-20 | Picorapid Technologie Gmbh | Substance support provided with a marking |
WO2004011664A2 (en) * | 2002-07-30 | 2004-02-05 | Astrazeneca Ab | Protein or carbohydrate profiling |
WO2004065543A2 (en) * | 2003-01-16 | 2004-08-05 | Exact Sciences Corporation | Devices and method for recovery of a target molecule from a sample |
WO2014060483A1 (en) * | 2012-10-17 | 2014-04-24 | Spatial Transcriptomics Ab | Methods and product for optimising localised or spatial detection of gene expression in a tissue sample |
JP2016052320A (en) * | 2009-12-04 | 2016-04-14 | 株式会社日立製作所 | Gene expression analysis method using two-dimensional cdna library |
US10472669B2 (en) | 2010-04-05 | 2019-11-12 | Prognosys Biosciences, Inc. | Spatially encoded biological assays |
EP3677692A1 (en) * | 2011-04-13 | 2020-07-08 | Spatial Transcriptomics AB | Method and product for localised or spatial detection of nucleic acid in a tissue sample |
US10774372B2 (en) | 2013-06-25 | 2020-09-15 | Prognosy s Biosciences, Inc. | Methods and systems for determining spatial patterns of biological targets in a sample |
US10774374B2 (en) | 2015-04-10 | 2020-09-15 | Spatial Transcriptomics AB and Illumina, Inc. | Spatially distinguished, multiplex nucleic acid analysis of biological specimens |
US10787701B2 (en) | 2010-04-05 | 2020-09-29 | Prognosys Biosciences, Inc. | Spatially encoded biological assays |
US11407992B2 (en) | 2020-06-08 | 2022-08-09 | 10X Genomics, Inc. | Methods of determining a surgical margin and methods of use thereof |
US11649485B2 (en) | 2019-01-06 | 2023-05-16 | 10X Genomics, Inc. | Generating capture probes for spatial analysis |
US11733238B2 (en) | 2010-04-05 | 2023-08-22 | Prognosys Biosciences, Inc. | Spatially encoded biological assays |
US11821035B1 (en) | 2020-01-29 | 2023-11-21 | 10X Genomics, Inc. | Compositions and methods of making gene expression libraries |
US11926867B2 (en) | 2019-01-06 | 2024-03-12 | 10X Genomics, Inc. | Generating capture probes for spatial analysis |
Families Citing this family (51)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6969614B1 (en) * | 1999-02-16 | 2005-11-29 | The United States Of America As Represented By The Department Of Health And Human Services | Methods for the isolation and analysis of cellular protein content |
US7214477B1 (en) * | 1999-07-26 | 2007-05-08 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Layered device with capture regions for cellular analysis |
US7838222B2 (en) * | 1999-07-26 | 2010-11-23 | United States of America/ NIH | Methods, devices and kits for multiplex blotting of biological samples from multi-well plates |
US6969615B2 (en) * | 1999-07-26 | 2005-11-29 | 20/20 Genesystems, Inc. | Methods, devices, arrays and kits for detecting and analyzing biomolecules |
US20060275851A1 (en) * | 2000-07-26 | 2006-12-07 | Emmert-Buck Michael R | Layered peptide/antigen arrays - for high-throughput antibody screening of clinical samples |
US20040053326A1 (en) * | 2001-03-14 | 2004-03-18 | Emmert-Buck Michael R. | Transfer microdessection |
US20040072274A1 (en) * | 2002-05-09 | 2004-04-15 | Lebrun Stewart J. | System and method for visualization and digital analysis of protein and other macromolecule microarrays |
WO2004048928A2 (en) * | 2002-11-25 | 2004-06-10 | The United States Of America As Represented By The Secretary Of Health And Human Services, Nih | Method and apparatus for performing multiple simultaneous manipulations of biomolecules in a two-dimensional array |
US20040171167A1 (en) * | 2002-12-13 | 2004-09-02 | Affymetrix, Inc. | Chip-in-a-well scanning |
KR20060027404A (en) * | 2003-07-07 | 2006-03-27 | 신젠타 파티서페이션즈 아게 | Reagents, methods and kits for detecting feed enzymes |
WO2005029055A1 (en) * | 2003-09-19 | 2005-03-31 | Invitrogen Corporation | Composite compositions for electrophoresis |
WO2005077537A1 (en) * | 2004-02-11 | 2005-08-25 | Pamgene B.V. | A device for analysing an interaction between target and probe molecules |
EP1853696B1 (en) | 2005-02-24 | 2019-04-17 | Life Technologies (Israel) Ltd. | Electro-blotting devices, systems, and kits, and methods for their use |
US20070258864A1 (en) * | 2005-12-08 | 2007-11-08 | Protein Discovery, Inc. | Methods and devices for concentration and fractionation of analytes for chemical analysis |
JP4915527B2 (en) * | 2007-09-27 | 2012-04-11 | 凸版印刷株式会社 | Electrophoresis / transfer laminate, electrophoresis / transfer chip, electrophoresis / transfer device, electrophoresis / transfer method, method for producing electrophoresis / transfer laminate |
WO2010006318A2 (en) * | 2008-07-11 | 2010-01-14 | Life Technologies Corporation | Electrophoretically enhanced detection of analytes on a solid support |
EP2425216B1 (en) * | 2009-04-27 | 2019-10-23 | Expedeon Holdings Ltd. | Programmable electrophoretic notch filter systems and methods |
US8524507B2 (en) * | 2009-08-19 | 2013-09-03 | The Cleveland Clinic Foundation | Method for detecting a target molecule in a biological sample |
AU2010306862B2 (en) | 2009-10-13 | 2015-08-27 | Nanostring Technologies, Inc. | Protein detection via nanoreporters |
JP2013178140A (en) * | 2012-02-28 | 2013-09-09 | Sharp Corp | Isolation device of nucleic acid-protein complex |
US9291596B2 (en) | 2013-02-12 | 2016-03-22 | Pierce Biotechnology, Inc. | Electroblot transfer buffer |
USD738527S1 (en) | 2013-05-28 | 2015-09-08 | Life Technologies Corporation | Electroblotting apparatus |
WO2015178249A1 (en) * | 2014-05-19 | 2015-11-26 | 国立大学法人名古屋大学 | Sample component analysis method, method of specific separation of components in sample, and sample for use in mass spectrometry |
SG10202107055SA (en) | 2015-07-17 | 2021-08-30 | Nanostring Technologies Inc | Simultaneous quantification of a plurality of proteins in a user-defined region of a cross-sectioned tissue |
SG10202107053QA (en) | 2015-07-17 | 2021-08-30 | Nanostring Technologies Inc | Simultaneous quantification of gene expression in a user-defined region of a cross-sectioned tissue |
US20190292259A1 (en) | 2016-05-24 | 2019-09-26 | Inserm (Institut National De La Sante Et De La Recherche Medicale) | Methods and pharmaceutical compositions for the treatment of non small cell lung cancer (nsclc) that coexists with chronic obstructive pulmonary disease (copd) |
WO2018046736A1 (en) | 2016-09-12 | 2018-03-15 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods for predicting the survival time of patients suffering from cancer |
WO2018055080A1 (en) | 2016-09-22 | 2018-03-29 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods and pharmaceutical compositions for reprograming immune environment in a subject in need thereof |
WO2018122249A1 (en) | 2016-12-28 | 2018-07-05 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods for predicting the survival time of patients suffering from a microsatellite stable colorectal cancer |
WO2018122245A1 (en) | 2016-12-28 | 2018-07-05 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods of predicting the survival time of patients suffering from cms3 colorectal cancer |
CA3061429A1 (en) | 2017-05-05 | 2018-11-08 | Inserm (Institut National De La Sante Et De La Recherche Medicale) | Microtubule-targeting drugs as immune checkpoint inhibitors and methods of screening novel immune checkpoint inhibitors for the treatment of cancers and infectious diseases |
WO2019157445A1 (en) | 2018-02-12 | 2019-08-15 | Nanostring Technologies, Inc. | Biomolecular probes and methods of detecting gene and protein expression |
CN109254346B (en) * | 2018-07-16 | 2020-09-11 | 哈尔滨工程大学 | Single-fiber optical tweezers based on wavelength division multiplexing technology |
CN109556939B (en) * | 2018-12-03 | 2021-05-11 | 中国科学院青藏高原研究所 | Method and equipment for observing fission track of sample by in-situ etching |
KR20220008253A (en) | 2019-01-03 | 2022-01-20 | 엥스띠뛰 나씨오날 드 라 쌍떼 에 드 라 흐쉐르슈 메디깔 (인쎄름) | Methods and pharmaceutical compositions for enhancing CD8+ T cell dependent immune response in a subject suffering from cancer |
US20220177978A1 (en) | 2019-04-02 | 2022-06-09 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods of predicting and preventing cancer in patients having premalignant lesions |
US20220160692A1 (en) | 2019-04-09 | 2022-05-26 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Use of sk2 inhibitors in combination with immune checkpoint blockade therapy for the treatment of cancer |
WO2020245155A1 (en) | 2019-06-03 | 2020-12-10 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods for modulating a treatment regimen |
WO2021074391A1 (en) | 2019-10-17 | 2021-04-22 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods for diagnosing nasal intestinal type adenocarcinomas |
US20230113705A1 (en) | 2020-02-28 | 2023-04-13 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods for diagnosing, prognosing and managing treatment of breast cancer |
EP4172621A1 (en) | 2020-06-30 | 2023-05-03 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods for predicting the risk of recurrence and/or death of patients suffering from a solid cancer after preoperative adjuvant therapies |
CN115843335A (en) | 2020-06-30 | 2023-03-24 | 国家医疗保健研究所 | Method for predicting the risk of relapse and/or death of a patient with solid cancer after preoperative adjuvant and radical surgery |
WO2022200303A1 (en) | 2021-03-23 | 2022-09-29 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods for the diagnosis and treatment of t cell-lymphomas |
WO2023144303A1 (en) | 2022-01-31 | 2023-08-03 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Cd38 as a biomarker and biotarget in t-cell lymphomas |
WO2023175366A1 (en) | 2022-03-17 | 2023-09-21 | Veracyte | Methods for predicting response to an immunotherapeutic treatment in a patient with a cancer |
WO2023198648A1 (en) | 2022-04-11 | 2023-10-19 | Institut National de la Santé et de la Recherche Médicale | Methods for the diagnosis and treatment of t-cell malignancies |
WO2023198874A1 (en) | 2022-04-15 | 2023-10-19 | Institut National de la Santé et de la Recherche Médicale | Methods for the diagnosis and treatment of t cell-lymphomas |
WO2024003310A1 (en) | 2022-06-30 | 2024-01-04 | Institut National de la Santé et de la Recherche Médicale | Methods for the diagnosis and treatment of acute lymphoblastic leukemia |
WO2024018046A1 (en) | 2022-07-22 | 2024-01-25 | Institut National de la Santé et de la Recherche Médicale | Garp as a biomarker and biotarget in t-cell malignancies |
WO2024023283A1 (en) | 2022-07-29 | 2024-02-01 | Institut National de la Santé et de la Recherche Médicale | Lrrc33 as a biomarker and biotarget in cutaneous t-cell lymphomas |
WO2024079192A1 (en) | 2022-10-12 | 2024-04-18 | Institut National de la Santé et de la Recherche Médicale | Cd81 as a biomarker and biotarget in t-cell malignancies |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4613567A (en) * | 1982-08-19 | 1986-09-23 | Konishiroku Photo Industry Co., Ltd. | Immunoassay method for measuring immunological antigen in fluid sample |
EP0525723A2 (en) * | 1991-07-29 | 1993-02-03 | Mochida Pharmaceutical Co., Ltd. | Process and device for specific binding assay |
US5486452A (en) * | 1981-04-29 | 1996-01-23 | Ciba-Geigy Corporation | Devices and kits for immunological analysis |
WO1998041863A1 (en) * | 1997-03-14 | 1998-09-24 | Compucyte Corp. | Multiple simultaneous testing media |
Family Cites Families (49)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3620947A (en) | 1969-04-10 | 1971-11-16 | Ortec Inc | Electrophoretic system |
DE2622684B2 (en) * | 1976-05-21 | 1979-03-15 | Licentia Patent-Verwaltungs-Gmbh, 6000 Frankfurt | Membrane exchanger |
US4337131A (en) | 1978-11-13 | 1982-06-29 | C. Desaga Gmbh Nachf. Erich Fecht | Process for electrophoresis |
US4668619A (en) * | 1980-10-30 | 1987-05-26 | Miles Laboratories, Inc. | Multilayer homogeneous specific binding assay device |
US4444879A (en) * | 1981-01-29 | 1984-04-24 | Science Research Center, Inc. | Immunoassay with article having support film and immunological counterpart of analyte |
JPS5818167A (en) * | 1981-07-24 | 1983-02-02 | Fuji Photo Film Co Ltd | Analyzing film and analysis using said film |
US4539294A (en) * | 1982-09-30 | 1985-09-03 | Akzona Incorporated | Immobilization of proteins on polymeric supports |
EP0139373A1 (en) * | 1983-08-26 | 1985-05-02 | The Regents Of The University Of California | Multiple immunoassay system |
DE3516579A1 (en) * | 1984-11-19 | 1986-05-22 | Boehringer Mannheim Gmbh, 6800 Mannheim | Coagulation test on test strips |
US4716101A (en) | 1984-12-18 | 1987-12-29 | Calgene, Inc. | Rapid enzyme assay by product selective blot |
US4795562A (en) | 1985-09-13 | 1989-01-03 | Walsh James W | Membrane batch-processing apparatus |
US4959305A (en) * | 1986-06-18 | 1990-09-25 | Miles Inc. | Reversible immobilization of assay reagents in a multizone test device |
US5057438A (en) * | 1986-09-24 | 1991-10-15 | Agency Of Industrial Science And Technology | Electrophoretic antigen-antibody determination with laminate of multiple membranes |
DE3638654A1 (en) * | 1986-11-12 | 1988-05-26 | Boehringer Mannheim Gmbh | TEST CARRIER FOR ANALYTICAL DETERMINATION OF A COMPONENT OF A BODY LIQUID |
US4840714A (en) | 1987-05-13 | 1989-06-20 | American Bionetics, Inc. | Electroblotting technique for transferring specimens from a polyacrylamide electrophoresis or like gel onto a membrane |
US4874691A (en) * | 1987-10-16 | 1989-10-17 | Quadra Logic Technologies Inc. | Membrane-supported immunoassays |
DE68919375T2 (en) | 1988-03-22 | 1995-06-14 | Nieman | Electrophoresis device. |
US5173159A (en) | 1988-09-06 | 1992-12-22 | Bertin & Cie | Multiple electrophoresis method for the controlled migration of macromolecules through rectangular gel plates |
GB8905001D0 (en) * | 1989-03-04 | 1989-04-19 | Univ Leicester | Screening for natural products of microbial metabolism |
US5155049A (en) | 1989-08-22 | 1992-10-13 | Terrapin Technologies, Inc. | Blotting technique for membrane assay |
US5238651A (en) | 1990-07-23 | 1993-08-24 | New York University | Gel plates, equipment and kits for combined electrophoretic-immunoelectrophoretic analysis |
CS257291A3 (en) | 1990-12-13 | 1992-06-17 | Jan J Prof Mudr Opplt | Multi-layered, non-sequential discontinuous polyacrylamide gels, forming equilibrium molecular sieves for biomolecules separation |
US5078853A (en) | 1991-03-22 | 1992-01-07 | Assay Technology, Inc. | Segmented electrophoretic separation system useful for lipid profiling |
CA2107905A1 (en) * | 1991-04-08 | 1992-10-09 | Kenneth Allen Blake | Multilayer test device matrix structure |
US5877028A (en) * | 1991-05-29 | 1999-03-02 | Smithkline Diagnostics, Inc. | Immunochromatographic assay device |
DE4132743A1 (en) * | 1991-10-02 | 1993-04-08 | Boehringer Mannheim Gmbh | TEST CARRIER FOR THE ANALYSIS OF LIQUIDS |
US5438128A (en) * | 1992-02-07 | 1995-08-01 | Millipore Corporation | Method for rapid purifiction of nucleic acids using layered ion-exchange membranes |
DE69427690T2 (en) | 1993-04-07 | 2002-05-02 | Gradipore Ltd | PROTEIN SEPARATION IMPROVEMENTS |
US5384255A (en) * | 1993-06-21 | 1995-01-24 | Rappaport Family Institute For Research In The Medical Sciences | Ubiquitin carrier enzyme E2-F1, purification, production, and use |
US5427664A (en) | 1993-07-22 | 1995-06-27 | Stoev; Stoyan V. | Free solution electrophoresis-membrane filters trapping assay apparatus and method |
US5332484A (en) | 1993-08-02 | 1994-07-26 | Hi-Tech Bio-Tech, Inc. | Apparatus and process for the large scale separation and retrieval of proteins from cellular extracts |
US5716508A (en) | 1993-09-09 | 1998-02-10 | Glyko Incorporated | Utilization of additives and defined storage systems to increase the stability and performance of electrophoresis media |
US5843657A (en) | 1994-03-01 | 1998-12-01 | The United States Of America As Represented By The Department Of Health And Human Services | Isolation of cellular material under microscopic visualization |
DE69422604T2 (en) | 1994-03-08 | 2000-06-08 | Zeptosens Ag Witterwil | Apparatus and method that combine bioaffinity assay and electrophoretic separation |
US5679310A (en) * | 1995-07-11 | 1997-10-21 | Polyfiltronics, Inc. | High surface area multiwell test plate |
US5665596A (en) * | 1995-07-31 | 1997-09-09 | Becton, Dickinson And Company | Device for cell co-culture and method for its use in culturing cells |
AU5427398A (en) | 1996-11-01 | 1998-05-29 | Grace Bio-Labs, Inc. | Cytoperfusion of tissue specimens |
GB9624927D0 (en) | 1996-11-29 | 1997-01-15 | Oxford Glycosciences Uk Ltd | Gels and their use |
US5804384A (en) * | 1996-12-06 | 1998-09-08 | Vysis, Inc. | Devices and methods for detecting multiple analytes in samples |
US6087134A (en) | 1997-01-14 | 2000-07-11 | Applied Imaging Corporation | Method for analyzing DNA from a rare cell in a cell population |
US6168929B1 (en) * | 1997-01-27 | 2001-01-02 | University Of Pittsburgh | Method of identifying agents that disrupt the interaction of SV40 T antigen with Dnak homologues |
US5993627A (en) | 1997-06-24 | 1999-11-30 | Large Scale Biology Corporation | Automated system for two-dimensional electrophoresis |
US6013165A (en) | 1998-05-22 | 2000-01-11 | Lynx Therapeutics, Inc. | Electrophoresis apparatus and method |
ES2214865T3 (en) * | 1998-06-24 | 2004-09-16 | CHEN & CHEN, LLC | MULTICAPE ANALYTICAL COLUMN. |
US6232067B1 (en) * | 1998-08-17 | 2001-05-15 | The Perkin-Elmer Corporation | Adapter directed expression analysis |
US6135942A (en) | 1998-11-30 | 2000-10-24 | Leptin; Maria | Nucleic acids proteins of a D. melanogaster insulin-like gene and uses thereof |
ATE268903T1 (en) | 1999-01-28 | 2004-06-15 | Univ Geneve | METHOD AND DEVICE FOR IDENTIFYING OR CHARACTERIZING POLYPEPTIDES |
US20020012920A1 (en) * | 2000-11-20 | 2002-01-31 | Kevin Gardner | Method and kit for proteomic identification |
US6969615B2 (en) * | 1999-07-26 | 2005-11-29 | 20/20 Genesystems, Inc. | Methods, devices, arrays and kits for detecting and analyzing biomolecules |
-
2000
- 2000-07-26 JP JP2001512292A patent/JP4137444B2/en not_active Expired - Lifetime
- 2000-07-26 DE DE60028393T patent/DE60028393T2/en not_active Expired - Lifetime
- 2000-07-26 AT AT00953685T patent/ATE328277T1/en not_active IP Right Cessation
- 2000-07-26 WO PCT/US2000/020354 patent/WO2001007915A2/en active IP Right Grant
- 2000-07-26 AU AU66091/00A patent/AU771499B2/en not_active Expired
- 2000-07-26 EP EP00953685A patent/EP1218743B1/en not_active Expired - Lifetime
- 2000-07-26 ES ES00953685T patent/ES2269171T3/en not_active Expired - Lifetime
- 2000-07-26 CA CA2375034A patent/CA2375034C/en not_active Expired - Lifetime
- 2000-11-20 US US09/718,990 patent/US6602661B1/en not_active Expired - Lifetime
-
2003
- 2003-07-25 US US10/627,352 patent/US20040081987A1/en not_active Abandoned
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5486452A (en) * | 1981-04-29 | 1996-01-23 | Ciba-Geigy Corporation | Devices and kits for immunological analysis |
US4613567A (en) * | 1982-08-19 | 1986-09-23 | Konishiroku Photo Industry Co., Ltd. | Immunoassay method for measuring immunological antigen in fluid sample |
EP0525723A2 (en) * | 1991-07-29 | 1993-02-03 | Mochida Pharmaceutical Co., Ltd. | Process and device for specific binding assay |
WO1998041863A1 (en) * | 1997-03-14 | 1998-09-24 | Compucyte Corp. | Multiple simultaneous testing media |
Non-Patent Citations (2)
Title |
---|
ENGLERT CHAD R ET AL: "Layered expression scanning: Rapid molecular profiling of tumor samples." CANCER RESEARCH, vol. 60, no. 6, 15 March 2000 (2000-03-15), pages 1526-1530, XP002156603 ISSN: 0008-5472 * |
See also references of EP1218743A2 * |
Cited By (80)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002010751A2 (en) * | 2000-07-26 | 2002-02-07 | The Government Of The United States Of America, As Represented By The Secretary, Department Of Health & Human Services | Transfer microdissection |
WO2002010751A3 (en) * | 2000-07-26 | 2002-04-25 | Government Of The Us Sec Dep O | Transfer microdissection |
WO2003014738A2 (en) * | 2001-08-02 | 2003-02-20 | Picorapid Technologie Gmbh | Substance support provided with a marking |
WO2003014738A3 (en) * | 2001-08-02 | 2003-11-13 | Picorapid Technologie Gmbh | Substance support provided with a marking |
WO2004011664A2 (en) * | 2002-07-30 | 2004-02-05 | Astrazeneca Ab | Protein or carbohydrate profiling |
WO2004011664A3 (en) * | 2002-07-30 | 2004-06-24 | Astrazeneca Ab | Protein or carbohydrate profiling |
WO2004065543A2 (en) * | 2003-01-16 | 2004-08-05 | Exact Sciences Corporation | Devices and method for recovery of a target molecule from a sample |
WO2004065543A3 (en) * | 2003-01-16 | 2004-12-23 | Exact Sciences Corp | Devices and method for recovery of a target molecule from a sample |
US11214796B2 (en) | 2009-12-04 | 2022-01-04 | Hitachi, Ltd. | Gene expression analysis ME1HOD using two dimensional cDNA library |
JP2016052320A (en) * | 2009-12-04 | 2016-04-14 | 株式会社日立製作所 | Gene expression analysis method using two-dimensional cdna library |
US10983113B2 (en) | 2010-04-05 | 2021-04-20 | Prognosys Biosciences, Inc. | Spatially encoded biological assays |
US10996219B2 (en) | 2010-04-05 | 2021-05-04 | Prognosys Biosciences, Inc. | Spatially encoded biological assays |
US10472669B2 (en) | 2010-04-05 | 2019-11-12 | Prognosys Biosciences, Inc. | Spatially encoded biological assays |
US10480022B2 (en) | 2010-04-05 | 2019-11-19 | Prognosys Biosciences, Inc. | Spatially encoded biological assays |
US10494667B2 (en) | 2010-04-05 | 2019-12-03 | Prognosys Biosciences, Inc. | Spatially encoded biological assays |
US10612079B2 (en) | 2010-04-05 | 2020-04-07 | Prognosys Biosciences, Inc. | Spatially encoded biological assays |
US10619196B1 (en) | 2010-04-05 | 2020-04-14 | Prognosys Biosciences, Inc. | Spatially encoded biological assays |
US10662467B2 (en) | 2010-04-05 | 2020-05-26 | Prognosys Biosciences, Inc. | Spatially encoded biological assays |
US10662468B2 (en) | 2010-04-05 | 2020-05-26 | Prognosys Biosciences, Inc. | Spatially encoded biological assays |
US11549138B2 (en) | 2010-04-05 | 2023-01-10 | Prognosys Biosciences, Inc. | Spatially encoded biological assays |
US11542543B2 (en) | 2010-04-05 | 2023-01-03 | Prognosys Biosciences, Inc. | System for analyzing targets of a tissue section |
US11866770B2 (en) | 2010-04-05 | 2024-01-09 | Prognosys Biosciences, Inc. | Spatially encoded biological assays |
US10787701B2 (en) | 2010-04-05 | 2020-09-29 | Prognosys Biosciences, Inc. | Spatially encoded biological assays |
US10914730B2 (en) | 2010-04-05 | 2021-02-09 | Prognosys Biosciences, Inc. | Spatially encoded biological assays |
US11519022B2 (en) | 2010-04-05 | 2022-12-06 | Prognosys Biosciences, Inc. | Spatially encoded biological assays |
US10962532B2 (en) | 2010-04-05 | 2021-03-30 | Prognosys Biosciences, Inc. | Spatially encoded biological assays |
US10961566B2 (en) | 2010-04-05 | 2021-03-30 | Prognosys Biosciences, Inc. | Spatially encoded biological assays |
US10982268B2 (en) | 2010-04-05 | 2021-04-20 | Prognosys Biosciences, Inc. | Spatially encoded biological assays |
US11560587B2 (en) | 2010-04-05 | 2023-01-24 | Prognosys Biosciences, Inc. | Spatially encoded biological assays |
US11371086B2 (en) | 2010-04-05 | 2022-06-28 | Prognosys Biosciences, Inc. | Spatially encoded biological assays |
US11001879B1 (en) | 2010-04-05 | 2021-05-11 | Prognosys Biosciences, Inc. | Spatially encoded biological assays |
US11001878B1 (en) | 2010-04-05 | 2021-05-11 | Prognosys Biosciences, Inc. | Spatially encoded biological assays |
US11008607B2 (en) | 2010-04-05 | 2021-05-18 | Prognosys Biosciences, Inc. | Spatially encoded biological assays |
US11634756B2 (en) | 2010-04-05 | 2023-04-25 | Prognosys Biosciences, Inc. | Spatially encoded biological assays |
US11067567B2 (en) | 2010-04-05 | 2021-07-20 | Prognosys Biosciences, Inc. | Spatially encoded biological assays |
US11156603B2 (en) | 2010-04-05 | 2021-10-26 | Prognosys Biosciences, Inc. | Spatially encoded biological assays |
US11479810B1 (en) | 2010-04-05 | 2022-10-25 | Prognosys Biosciences, Inc. | Spatially encoded biological assays |
US11767550B2 (en) | 2010-04-05 | 2023-09-26 | Prognosys Biosciences, Inc. | Spatially encoded biological assays |
US11208684B2 (en) | 2010-04-05 | 2021-12-28 | Prognosys Biosciences, Inc. | Spatially encoded biological assays |
US11401545B2 (en) | 2010-04-05 | 2022-08-02 | Prognosys Biosciences, Inc. | Spatially encoded biological assays |
US11761030B2 (en) | 2010-04-05 | 2023-09-19 | Prognosys Biosciences, Inc. | Spatially encoded biological assays |
US11293917B2 (en) | 2010-04-05 | 2022-04-05 | Prognosys Biosciences, Inc. | Systems for analyzing target biological molecules via sample imaging and delivery of probes to substrate wells |
US11732292B2 (en) | 2010-04-05 | 2023-08-22 | Prognosys Biosciences, Inc. | Spatially encoded biological assays correlating target nucleic acid to tissue section location |
US11313856B2 (en) | 2010-04-05 | 2022-04-26 | Prognosys Biosciences, Inc. | Spatially encoded biological assays |
US11384386B2 (en) | 2010-04-05 | 2022-07-12 | Prognosys Biosciences, Inc. | Spatially encoded biological assays |
US11733238B2 (en) | 2010-04-05 | 2023-08-22 | Prognosys Biosciences, Inc. | Spatially encoded biological assays |
US11365442B2 (en) | 2010-04-05 | 2022-06-21 | Prognosys Biosciences, Inc. | Spatially encoded biological assays |
US11788122B2 (en) | 2011-04-13 | 2023-10-17 | 10X Genomics Sweden Ab | Methods of detecting analytes |
US11352659B2 (en) | 2011-04-13 | 2022-06-07 | Spatial Transcriptomics Ab | Methods of detecting analytes |
EP4206333A1 (en) * | 2011-04-13 | 2023-07-05 | Spatial Transcriptomics AB | Composition for localised or spatial detection of nucleic acid in a tissue sample |
EP4183887A1 (en) * | 2011-04-13 | 2023-05-24 | Spatial Transcriptomics AB | Method and product for localised or spatial detection of nucleic acid in a tissue sample |
US11479809B2 (en) | 2011-04-13 | 2022-10-25 | Spatial Transcriptomics Ab | Methods of detecting analytes |
US11795498B2 (en) | 2011-04-13 | 2023-10-24 | 10X Genomics Sweden Ab | Methods of detecting analytes |
EP3677692A1 (en) * | 2011-04-13 | 2020-07-08 | Spatial Transcriptomics AB | Method and product for localised or spatial detection of nucleic acid in a tissue sample |
WO2014060483A1 (en) * | 2012-10-17 | 2014-04-24 | Spatial Transcriptomics Ab | Methods and product for optimising localised or spatial detection of gene expression in a tissue sample |
EP3901280A1 (en) * | 2012-10-17 | 2021-10-27 | Spatial Transcriptomics AB | Methods and product for optimising localised or spatial detection of gene expression in a tissue sample |
EP3511423A1 (en) * | 2012-10-17 | 2019-07-17 | Spatial Transcriptomics AB | Methods and product for optimising localised or spatial detection of gene expression in a tissue sample |
US9593365B2 (en) | 2012-10-17 | 2017-03-14 | Spatial Transcriptions Ab | Methods and product for optimising localised or spatial detection of gene expression in a tissue sample |
US10774372B2 (en) | 2013-06-25 | 2020-09-15 | Prognosy s Biosciences, Inc. | Methods and systems for determining spatial patterns of biological targets in a sample |
US11359228B2 (en) | 2013-06-25 | 2022-06-14 | Prognosys Biosciences, Inc. | Methods and systems for determining spatial patterns of biological targets in a sample |
US11618918B2 (en) | 2013-06-25 | 2023-04-04 | Prognosys Biosciences, Inc. | Methods and systems for determining spatial patterns of biological targets in a sample |
US11286515B2 (en) | 2013-06-25 | 2022-03-29 | Prognosys Biosciences, Inc. | Methods and systems for determining spatial patterns of biological targets in a sample |
US11821024B2 (en) | 2013-06-25 | 2023-11-21 | Prognosys Biosciences, Inc. | Methods and systems for determining spatial patterns of biological targets in a sample |
US10927403B2 (en) | 2013-06-25 | 2021-02-23 | Prognosys Biosciences, Inc. | Methods and systems for determining spatial patterns of biological targets in a sample |
US11046996B1 (en) | 2013-06-25 | 2021-06-29 | Prognosys Biosciences, Inc. | Methods and systems for determining spatial patterns of biological targets in a sample |
US11753674B2 (en) | 2013-06-25 | 2023-09-12 | Prognosys Biosciences, Inc. | Methods and systems for determining spatial patterns of biological targets in a sample |
US11390912B2 (en) | 2015-04-10 | 2022-07-19 | Spatial Transcriptomics Ab | Spatially distinguished, multiplex nucleic acid analysis of biological specimens |
US11299774B2 (en) | 2015-04-10 | 2022-04-12 | Spatial Transcriptomics Ab | Spatially distinguished, multiplex nucleic acid analysis of biological specimens |
US11739372B2 (en) | 2015-04-10 | 2023-08-29 | Spatial Transcriptomics Ab | Spatially distinguished, multiplex nucleic acid analysis of biological specimens |
US11613773B2 (en) | 2015-04-10 | 2023-03-28 | Spatial Transcriptomics Ab | Spatially distinguished, multiplex nucleic acid analysis of biological specimens |
US11162132B2 (en) | 2015-04-10 | 2021-11-02 | Spatial Transcriptomics Ab | Spatially distinguished, multiplex nucleic acid analysis of biological specimens |
US10774374B2 (en) | 2015-04-10 | 2020-09-15 | Spatial Transcriptomics AB and Illumina, Inc. | Spatially distinguished, multiplex nucleic acid analysis of biological specimens |
US11753675B2 (en) | 2019-01-06 | 2023-09-12 | 10X Genomics, Inc. | Generating capture probes for spatial analysis |
US11649485B2 (en) | 2019-01-06 | 2023-05-16 | 10X Genomics, Inc. | Generating capture probes for spatial analysis |
US11926867B2 (en) | 2019-01-06 | 2024-03-12 | 10X Genomics, Inc. | Generating capture probes for spatial analysis |
US11821035B1 (en) | 2020-01-29 | 2023-11-21 | 10X Genomics, Inc. | Compositions and methods of making gene expression libraries |
US11781130B2 (en) | 2020-06-08 | 2023-10-10 | 10X Genomics, Inc. | Methods of determining a surgical margin and methods of use thereof |
US11407992B2 (en) | 2020-06-08 | 2022-08-09 | 10X Genomics, Inc. | Methods of determining a surgical margin and methods of use thereof |
US11492612B1 (en) | 2020-06-08 | 2022-11-08 | 10X Genomics, Inc. | Methods of determining a surgical margin and methods of use thereof |
US11624063B2 (en) | 2020-06-08 | 2023-04-11 | 10X Genomics, Inc. | Methods of determining a surgical margin and methods of use thereof |
Also Published As
Publication number | Publication date |
---|---|
ATE328277T1 (en) | 2006-06-15 |
US6602661B1 (en) | 2003-08-05 |
EP1218743B1 (en) | 2006-05-31 |
EP1218743A2 (en) | 2002-07-03 |
AU771499B2 (en) | 2004-03-25 |
CA2375034A1 (en) | 2001-02-01 |
WO2001007915A3 (en) | 2001-04-05 |
US20040081987A1 (en) | 2004-04-29 |
AU6609100A (en) | 2001-02-13 |
DE60028393D1 (en) | 2006-07-06 |
JP4137444B2 (en) | 2008-08-20 |
ES2269171T3 (en) | 2007-04-01 |
JP2003505694A (en) | 2003-02-12 |
CA2375034C (en) | 2012-01-03 |
DE60028393T2 (en) | 2007-06-14 |
WO2001007915A8 (en) | 2001-11-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2375034C (en) | Method and device for analysis of biological specimens | |
US7214477B1 (en) | Layered device with capture regions for cellular analysis | |
AU772680B2 (en) | LCM (Laser capture microdissection) for cellular protein analysis | |
Craven et al. | Laser capture microdissection and two-dimensional polyacrylamide gel electrophoresis: evaluation of tissue preparation and sample limitations | |
Emmert‐Buck et al. | An approach to proteomic analysis of human tumors | |
US6969615B2 (en) | Methods, devices, arrays and kits for detecting and analyzing biomolecules | |
Simon et al. | Tissue microarrays for miniaturized high-throughput molecular profiling of tumors | |
JP2024037825A (en) | Representative diagnostic method | |
US6969614B1 (en) | Methods for the isolation and analysis of cellular protein content | |
Cowherd et al. | Proteomic analysis of human breast cancer tissue with laser-capture microdissection and reverse-phase protein microarrays | |
Sabel et al. | Proteomics in melanoma biomarker discovery: great potential, many obstacles | |
Song et al. | Correlation between PD-L1 expression and clinicopathologic features in 404 patients with lung adenocarcinoma | |
CA2428441A1 (en) | Methods, devices, arrays and kits for detecting and analyzing biomolecules | |
WO2002077176A2 (en) | Aberrantly expressed proteins in laser capture microdissected tumors | |
Craven et al. | [4] Use of laser capture microdissection to selectively obtain distinct populations of cells for proteomic analysis | |
US20040053326A1 (en) | Transfer microdessection | |
Jain | [14] Application of laser capture microdissection to proteomics | |
Sreekumar et al. | Using protein microarrays to study cancer | |
Lee et al. | Revealing urologic diseases by proteomic techniques | |
CA2415864A1 (en) | Transfer microdissection | |
US20060147926A1 (en) | Method and apparatus for performing multiple simultaneous manipulations of biomolecules in a two-dimensional array | |
US20230097123A1 (en) | Methods and kits for identifying, diagnosing and treating prostate carcinomas | |
Tangrea et al. | Layered expression scanning: multiplex analysis of RNA and protein gels | |
JP7259019B2 (en) | Size-based gating for analyzing flow cytometry data | |
Alaiya et al. | Clinical cancer proteomics |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 09718990 Country of ref document: US |
|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: C1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: C1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
CFP | Corrected version of a pamphlet front page | ||
CR1 | Correction of entry in section i | ||
ENP | Entry into the national phase |
Ref document number: 2375034 Country of ref document: CA Ref country code: CA Ref document number: 2375034 Kind code of ref document: A Format of ref document f/p: F |
|
WWE | Wipo information: entry into national phase |
Ref document number: 66091/00 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10048194 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2000953685 Country of ref document: EP |
|
AK | Designated states |
Kind code of ref document: B8 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: B8 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
WR | Later publication of a revised version of an international search report | ||
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWP | Wipo information: published in national office |
Ref document number: 2000953685 Country of ref document: EP |
|
WWG | Wipo information: grant in national office |
Ref document number: 66091/00 Country of ref document: AU |
|
WWG | Wipo information: grant in national office |
Ref document number: 2000953685 Country of ref document: EP |